Jewell Christopher M
- SEC CIK
- 0002000226
No open-market purchases or sales filed in the past year.
Current role at each company
- RNAC Cartesian Therapeutics, Inc.Chief Scientific Officeras of Jan 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jewell Christopher M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Jewell Christopher MChief Scientific Officer | SSale | −2.55K | $16.78 | −$42.8K | −4.6%53.5K after | 2 lots |
| Nov 18, 2024 (view filing) | Nov 14-15 | 4 days | Jewell Christopher MChief Scientific Officer | SSale | −52.1K | $16.79 | −$875.0K | −66.8%25.9K after | 3 lots |